Pseudorabies Vaccine, Live Strain Bartha-K61

• Varieties: Vaccine
• Component: Virus
• Type: The First Class
• Shipping Cost: Estimated freight per unit.: about shipping cost and estimated delivery time.
• Currency: US$
• Return&refunds: You can apply for a refund up to 30 days after receipt of the products.
• Model NO.: Strain Bartha-K61
• Pharmacodynamic Influential Factors: Virus
• Storage Method: Prevent High or LowTemperature
• Veterinary Reg. No.: 154397018
• Usage: Administer Via Intramuscular Injection in The Neck
• Shelf Life: 18 Months
• Temperature: Store at -20ºC
• Withdrawal Period: 0 Day
• Package: 700 Bottles / Carton
• Transport Package: Air Way/Sea Way
• Specification: 10 dose/vial; 20 doses/ vial; 50 doses/vial
• Trademark: SINDER
• Origin: China
• Production Capacity: 100000L/Year
• Package Size: 61.20cm * 34.50cm * 41.00cm
• Package Gross Weight: 20.000kg

Product Description

GENERIC NAME:
Pseudorabies Vaccine, Live (Strain Bartha-K61)
COMPOSITION:
Pseudorabies virus (Bartha-K61 strain) ≥ 5x10^3.0TCID₅₀/dose.
CHARACTERISTIC:
The product presents as sponge-like, loosely-packed clusters that easily disengage from the bottle wall, and rapid dissolution in the PBS.
INDICATION(S):
The product is used to prevent the Pseudorabies in pigs, cattle and sheep. The immunity will be generated at the 6th day after administration, and providing protection for a duration of 12 months.
ADMINISTRATION AND DOSAGE:
Administer via intramuscular injection. Dilute with PBS to achieve a concentration of 1 dose/ml as indicated on the label.
Swine:
Pregnant sows and adult pigs: 2.0ml per head
Pigs aged 3 months and older (including feeder pigs): 1.0ml per head
Piglets: Initial vaccination of 0.5ml, subsequent post-weaning dose of 1.0ml
Cattle:
Cattle aged 1 year and above: 3.0ml per head
Cattle aged 5-12 months: 2.0ml per head
Calves aged 2-4 months: Initial vaccination of 1.0ml, post-weaning dose of 2.0ml
Sheep:
Sheep aged 4 months and older: 1.0ml per head
SPECIAL WARNING IF NECESSARY:

1. Ensure that the vaccine is utilized on the day of opening the vial to maintain its efficacy.
2. Before administration, ensure local disinfection measures are taken.
3. Optimal timing for vaccination in pregnant sows falls within 21-28 days before parturition. Maternally derived antibodies in piglets born to vaccinated sows remain effective for 21-28 days. Subsequent vaccination is required for piglets or weaned pigs. Unvaccinated sows' offspring can be vaccinated within 7 days postpartum and again after weaning.
4. In regions under disease threat or within an endemic area, urgent vaccination is warranted for all livestock, including asymptomatic animals. This proactive approach encompasses not only diseased animals but also those showing no clinical manifestations.
5. Disposal of used vaccine vials, equipment, and any remaining vaccine should adhere to proper procedures to ensure safe and eco-friendly disposal.

 Pseudorabies Vaccine, Live (Bartha-K61 strain)
(1) High titer, antigen titer is stable for different batches.
(2) Classic Bartha-K61 strain with a natural deletion of the gE gene, easy to differential diagnosis and prevention of pseudorabies.
(3) Triple detections of raw materials, production processes, and finished products to ensure no contamination by mycoplasma, BVDV or other exogenous pathogens.

Shandong Sinder Technology Co., Ltd ('Sinder') founded in April 1999, has a wide range of animal health products. Sinder focus on Animal Health Products, Animal Vaccine, Antibodies, Antibiotics, Feed Additives, Chinese Herbal Product, Pet food, Elisa, and PCR test kit.

Sinder always persists in the core concept of 'The Relentless Pursuit of Increasing Customer Value. ' Based on the animal health to achieve a service provider for ecological construction of agriculture and animal husbandry. Support the efficient and sustainable development of agriculture and animal husbandry. Make food safer and rural areas better!

Sinder is a high-tech enterprise and one of the top 10 veterinary drug manufacturers in China and focusing on the animal health business. At the moment, the company has 35 GMP production lines, 1 CNAS laboratory, 3 national scientific research platforms, and 8 provincial scientific research platforms owned by Sinder.

Sinder has 4 R&D centers located in Qingdao, Zhucheng, and Beijing, China, and 1 laboratory in Silicon Valley in the United States. At present, the company has 1,535 employees including more than 200 masters or above and 18 doctors. Also, the company established extensive technical cooperation with several domestic and foreign scientific research institutes, animal health companies, and domestic veterinary medicine enterprises. Sinder has undertaken 57 national, provincial, and ministerial projects, gained 7 provincial and ministerial science and technology progress awards, presided over or participated in 23 national standards, obtained 23 new veterinary drug certificates(one 1st class new drug), and 60 authorized patents.